Recon: Novartis set to purchase Mariana for $1B; FDA requests more data on Dupixent for COPD
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesReconJason ScottBiologics/ biosimilars/ vaccinesEuropeGlobalNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States